These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 15208174)

  • 1. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.
    Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.
    Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis.
    Seror R; Tubach F; Baron G; Falissard B; Logeart I; Dougados M; Ravaud P
    Ann Rheum Dis; 2008 Apr; 67(4):494-9. PubMed ID: 17704063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factor subdimensions of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) help to specify hip and knee osteoarthritis. a prospective evaluation and validation study.
    Angst F; Ewert T; Lehmann S; Aeschlimann A; Stucki G
    J Rheumatol; 2005 Jul; 32(7):1324-30. PubMed ID: 15996072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
    Ehrich EW; Davies GM; Watson DJ; Bolognese JA; Seidenberg BC; Bellamy N
    J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes.
    Hamel MB; Toth M; Legedza A; Rosen MP
    Arch Intern Med; 2008 Jul; 168(13):1430-40. PubMed ID: 18625924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of limitations in activities in osteoarthritis of the hip or knee: a 3-year cohort study.
    van Dijk GM; Veenhof C; Spreeuwenberg P; Coene N; Burger BJ; van Schaardenburg D; van den Ende CH; Lankhorst GJ; Dekker J;
    Arch Phys Med Rehabil; 2010 Jan; 91(1):58-66. PubMed ID: 20103397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design.
    Ravaud P; Giraudeau B; Logeart I; Larguier JS; Rolland D; Treves R; Euller-Ziegler L; Bannwarth B; Dougados M
    Ann Rheum Dis; 2004 Jun; 63(6):703-8. PubMed ID: 15140778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis.
    Baron G; Tubach F; Ravaud P; Logeart I; Dougados M
    Arthritis Rheum; 2007 May; 57(4):633-8. PubMed ID: 17471534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index.
    Escobar A; Quintana JM; Bilbao A; Azkárate J; Güenaga JI
    Clin Rheumatol; 2002 Nov; 21(6):466-71. PubMed ID: 12447629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study.
    Tubach F; Ravaud P; Martin-Mola E; Awada H; Bellamy N; Bombardier C; Felson DT; Hajjaj-Hassouni N; Hochberg M; Logeart I; Matucci-Cerinic M; van de Laar M; van der Heijde D; Dougados M
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1699-707. PubMed ID: 22674853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
    Detora LM; Krupa D; Bolognese J; Sperling RS; Ehrich EW
    J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.
    Winther K; Apel K; Thamsborg G
    Scand J Rheumatol; 2005; 34(4):302-8. PubMed ID: 16195164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE; Holme I; Høye K; Ringertz B
    Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention.
    Angst F; Aeschlimann A; Steiner W; Stucki G
    Ann Rheum Dis; 2001 Sep; 60(9):834-40. PubMed ID: 11502609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.).
    Wegener T; Lüpke NP
    Phytother Res; 2003 Dec; 17(10):1165-72. PubMed ID: 14669250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.